Opiate immunoassay reagent kits in support of the drug demand reduction program
Ended Awarded
- Contract number
- N6854625FA100
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $5,423
Award facts
- Contract value 100% obligated
- $5,423.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Navy Bureau of Medicine and Surgery awarded a $5,423.20 firm fixed-price delivery order to Microgenics Corporation for opiate immunoassay reagent kits in support of the Drug Demand Reduction Program. The contract, with an ultimate completion date of October 17, 2025, represents a continuation of the agency's ongoing procurement of specialized diagnostic testing supplies. Microgenics Corporation, a clinical diagnostics manufacturer based in Fremont, California, and a subsidiary of Thermo Electron Corporation, specializes in producing high-precision immunoassay reagent test kits designed to detect controlled substances and support substance abuse screening programs across military and veterans healthcare systems. The award was made without a set-aside designation, reflecting Microgenics' competitive standing in the federal marketplace.
This delivery order is issued under Microgenics' larger indefinite delivery vehicle for opiate reagent kits valued at $750,435.30 with the Navy Bureau of Medicine and Surgery. The company maintains multiple significant federal contracts for various immunoassay reagent products, including kits for benzodiazepines, MDMA/MDA, amphetamines, methamphetamine, hydrocodone, and opiates, collectively supporting the Department of Defense's substance abuse testing and treatment initiatives. These contracts enable the military and veterans healthcare systems to conduct critical toxicology screenings and maintain comprehensive drug demand reduction efforts across their populations.
Quick answers
Who was awarded contract N6854625FA100?
N6854625FA100 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on September 6, 2025.
How much is contract N6854625FA100 worth?
The government has obligated $5,423 on N6854625FA100.
Is contract N6854625FA100 an order under another contract?
Yes. N6854625FA100 is a delivery order under N6264523D5006, an indefinite delivery contract.
Was contract N6854625FA100 competed?
The extent of competition for N6854625FA100 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award